ClinicalTrials.gov
public full text
Public Domain
Immunomodulatory Properties of Ketamine in Sepsis
The aim of the study is to assess the effect of short-term infusion of ketamine at analgesic dosage on the immune response, morbidity and mortality among patients suffering from septic shock. We hypothesize that ketamine will modulate the cytokine response to sepsis and reduce morbidity and mortality.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post-traumatic Acute Pain in the Emergency Department ( INVESCK )#847484
- Ketamine Versus Low Dose Thiopental for Induction of Anesthesia in Septic Shock#1094418
- Effects of Dexmedetomidine Versus Ketamine on Inflammatory Response and Hemodynamic in Patients#1030562
- Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients#1161867
- Pathophysiology and Management of Sepsis-associated Acute Kidney Injury.#615762
Record · ID 1243532
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive